Monaco Clinical Oncology NGS Market (2025-2031) | Analysis, Value, Segmentation, Forecast, Size & Revenue, Competitive Landscape, Trends, Industry, Growth, Companies, Share, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Monaco Country Macro Economic Indicators

3.2 Monaco Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 Monaco Clinical Oncology NGS Market - Industry Life Cycle

3.4 Monaco Clinical Oncology NGS Market - Porter's Five Forces

3.5 Monaco Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 Monaco Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.7 Monaco Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.8 Monaco Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of cancer cases driving the demand for advanced oncology diagnostics and treatments.

4.2.2 Technological advancements in Next-Generation Sequencing (NGS) enabling more efficient and accurate clinical oncology testing.

4.2.3 Growing focus on personalized medicine and targeted therapies in oncology leading to higher adoption of NGS in clinical settings.

4.3 Market Restraints

4.3.1 High cost associated with NGS testing and equipment limiting accessibility for some healthcare facilities and patients.

4.3.2 Regulatory challenges and compliance requirements impacting the pace of adoption and implementation of NGS technologies in clinical oncology.

6.1 Monaco Clinical Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 Monaco Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 Monaco Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 Monaco Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.1.5 Monaco Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F

6.2 Monaco Clinical Oncology NGS Market, By Workflow

6.2.1 Overview and Analysis

6.2.2 Monaco Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.2.3 Monaco Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.2.4 Monaco Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F

6.3 Monaco Clinical Oncology NGS Market, By Application

6.3.1 Overview and Analysis

6.3.2 Monaco Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F

6.3.3 Monaco Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F

6.3.4 Monaco Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F

6.4 Monaco Clinical Oncology NGS Market, By End-use

6.4.1 Overview and Analysis

6.4.2 Monaco Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Monaco Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Monaco Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F

7.1 Monaco Clinical Oncology NGS Market Export to Major Countries

7.2 Monaco Clinical Oncology NGS Market Imports from Major Countries

8.1 Average turnaround time for NGS testing in clinical oncology.

8.2 Rate of adoption of NGS for oncology diagnostics among healthcare providers.

8.3 Number of clinical trials incorporating NGS technologies for oncology research and treatment development.

9.1 Monaco Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 Monaco Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.3 Monaco Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.4 Monaco Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 Monaco Clinical Oncology NGS Market Revenue Share, By Companies, 2024

10.2 Monaco Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters